Your basket is currently empty!
Methylene Blue and Stroke: Can It Protect the Brain and Aid Recovery?
Reading Time: 9 minutes. Methylene blue shows promise for protecting your brain during stroke by stabilising mitochondrial function and enhancing ATP production, even in oxygen-deprived tissue. In experimental models, it has reduced infarct volumes by 30-50% and extended the therapeutic window when administered within 60 minutes of stroke onset. The compound acts as an alternative electron…
Methylene Blue and Huntington’s Disease: What Research Reveals
Reading Time: 9 minutes. Research shows that methylene blue disrupts huntingtin protein aggregates that cause Huntington’s disease by interfering with hydrogen-bonding networks and β-sheet formation. Studies demonstrate it effectively blocks aggregate formation in cell cultures, extends lifespan in Drosophila models, and delays symptom onset in R6/2 mice when treatment begins early. The compound also enhances…
Why Neurological Diseases Impede Cognitive Function
Reading Time: 5 minutes. Neurological diseases negatively impact cognitive function, presenting significant challenges for individuals and their loved ones. Alzheimer’s Disease, Parkinson’s Disease, Multiple Sclerosis, Huntington’s Disease, and Traumatic Brain Injury all contribute to cognitive decline, impairment, dysfunction, and deficits. These conditions impact memory, attention, language, problem-solving, and other cognitive functions essential for daily functioning.…
World Mental Health Day 2025: How Our Environment Shapes Brain Health
Reading Time: 14 minutes. Our surroundings are not neutral backdrops; they actively shape the way our brains grow and age. The constant assault of urban noise and polluted air inflames the nervous system, disrupts sleep, and drives up rates of anxiety and depression. On the other hand, when we raise children near parks and trees,…
Methylene Blue and ALS (Amyotrophic Lateral Sclerosis): Hope or Hype?
Reading Time: 6 minutes. Despite methylene blue‘s compelling biochemical rationale—it enhances mitochondrial function, reduces oxidative stress, and dampens neuroinflammation—you’ll find its track record in ALS research disappointingly underwhelming. The compound showed no survival benefit or motor improvement in SOD1(G93A) mouse models, the gold standard for preclinical ALS testing. While simpler organisms, such as C. elegans,…
